Sales of the firm's infectious disease and women's health products were credited with driving the year-over-year increase in revenues.
The firm launched the multiplex PCR-based test this week on its Spartan Cube platform to support patient enrollment in Alzheimer's clinical trials.
A group from the University of Minnesota found that quantitative and qualitative errors in NGS library prep could be eliminated by changing four parameters in a common workflow.
The agency has doubled the window after suspected exposure during which it recommends RT-qPCR testing for some pregnant women.
The molecular test is now the first FDA-cleared assay to monitor treatment response and disease clearance in chronic myeloid leukemia patients.
In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.
At Nature, John Wilbanks and Eric Topol call for openness in health data.
Law.com predicts that genomic and genetic testing will become common in toxic tort cases.
A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.